Evidence map›Paper›PMID 41742338›Full record

Observational studyThe Pediatric infectious disease journal2026

Empiric Antibiotic Prescription Patterns in Children With Cerebrospinal Fluid Shunt Infection.

Evan Heller, Panteha Hayati Rezvan, Susan E Coffin, Jason S Hauptman, Matthew P Kronman, Francesco T Mangano, Stacey Podkovik, Ian F Pollack, Joshua K Schaffzin, Benjamin C Warf and 3 more

Abstract readObservational Study
In one paragraph

Observational study in The Pediatric infectious disease journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Evan HellerFrom the Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah.
Panteha Hayati RezvanThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.
Susan E CoffinDepartment of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
Jason S HauptmanDepartment of Neurological Surgery, University of Washington School of Medicine.
Matthew P KronmanDepartment of Pediatrics, School of Medicine, University of Washington, Seattle, Washington.
Francesco T ManganoDepartment of Neurosurgery, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Stacey PodkovikDepartment of Neurological Surgery, Riverside University Health Sciences Medical Center, Riverside, California.
Ian F PollackDepartment of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Joshua K SchaffzinDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Benjamin C WarfDepartment of Neurosurgery, Harvard School of Medicine, Boston, Massachusetts.
Chuan ZhouDepartment of Pediatrics, School of Medicine, University of Washington, Seattle, Washington.
Tamara D SimonThe Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California.ORCID 0000-0003-4734-7020
Emily A ThorellFrom the Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah.

Funding

Transform Dissemination and Implementation Science in CTSA ProgramsUL1TR002319 · NCATS · UNIVERSITY OF WASHINGTON · PI John K. Amory · 2017 to 2026
$100.0M
Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
Southern California Clinical and Translational Science InstituteUL1TR000130 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BUCHANAN, THOMAS A · 2012 to 2015
$36.0M
Prevention of Cerebrospinal Fluid (CSF) Shunt InfectionsR01NS101029 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI SIMON, TAMARA DANIELLE · 2018 to 2022
$2.2M
NCATS NIH HHS UL1 TR000130NCATS NIH HHS UL1 TR001855NCATS NIH HHS UL1 TR002319NINDS NIH HHS R01 NS101029
6 · The paper itself

Abstract

backgroundInfectious Diseases Society of America guidelines recommend vancomycin plus an antipseudomonal beta-lactam (cefepime, ceftazidime or meropenem) in most cases, with adjustments based on local susceptibility patterns. The objective of this study was to determine patterns of inpatient antibiotic use in children undergoing empiric treatment of cerebrospinal (CSF) shunt infection.

methodsRetrospective, observational cohort study at 6 tertiary care children's hospitals among children who developed first shunt infection following initial CSF shunt placement surgery between 2007 and 2012. Primary outcome was use of antimicrobials as empiric therapy, defined as any antibiotic order on the day prior, day of and day after the neurosurgical procedure to treat the infection (ie, occurring before culture results typically guide antibiotic selection). We conducted analyses at the infection and hospital levels from 2007 to 2015.

resultsThe 181 children who received empiric antibiotics most received vancomycin (n = 155, 85.6%), cefazolin (n = 65, 35.9%), ceftriaxone (n = 55, 30.4%), cefotaxime (n = 43, 23.8%) and cefepime (n = 36, 19.9%). Few children received combinations of empiric antibiotic combinations recommended by the Infectious Diseases Society of America guidelines: vancomycin and cefepime (n = 7, 3.6%), vancomycin and ceftazidime (n = 0, 0%) or vancomycin and meropenem (n = 1, 0.5%). There was no evidence indicating a change in antimicrobial coverage over the study period.

conclusionsEmpiric therapy for CSF shunt infections represents a key opportunity for antimicrobial stewardship programs to ensure guideline concordance and promote appropriate antibiotic use.

Indexed as

Anti-Bacterial AgentsCerebrospinal Fluid ShuntsPractice Patterns, Physicians'AdolescentChildChild, PreschoolCohort StudiesFemaleFirst Generation CephalosporinsHospitals, PediatricHumansInfantMaleRetrospective StudiesSecond Generation CephalosporinsThird Generation CephalosporinsAnti-Bacterial AgentsFirst Generation CephalosporinsSecond Generation CephalosporinsThird Generation CephalosporinsVancomycinantibioticcerebrospinal fluid shuntempiricinfectionpediatrictreatment

Identifiers

PMID41742338
PMCPMC13375159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.